GlassScriptPhysician profile
Shawn Sedgh
NPI 1659935062
$2,222.85
in general payments reported to CMS, 2019-2025
12 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 80% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $35.93 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noctrix Health, INC. | $725.72 | 2025 | Nidra |
| Ucb, INC. | $327.18 | 2024-2025 | Fintepla, Nayzilam, Briviact |
| Sk Life Science, INC. | $233.17 | 2025 | |
| Genentech, INC. | $227.62 | 2025 | Ocrevus, Ocrevus Zunovo |
| Genzyme Corporation | $147.95 | 2025 | |
| Argenx US, INC. | $144.61 | 2025 | Vyvgart Hytrulo |
| Otsuka America Pharmaceutical, INC. | $117.87 | 2025 | Rexulti |
| Ipsen Biopharmaceuticals, INC | $92.94 | 2025 | Dysport |
| Ani Pharmaceuticals, INC. | $81.04 | 2025 | Purified Cortrophin Gel |
| Ge Healthcare | $50.26 | 2025 | |
| Mdd US Operations, LLC | $43.31 | 2025 | |
| Amgen INC. | $31.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Sedgh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.